October 2014 Monthly Test Update

Published on 10/07/14

Recent Test Updates

EGL recently updated the following tests: 

  • MM140 Peroxisome Biogenesis Disorders, Zellweger Syndrome Spectrum: Sequencing Panel - Removed ABCD1 from gene list
  • MM340 Neonatal and Adult Cholestasis: Sequencing Panel - Removed ACBD1 from gene list
  • MXIL1 X-linked Intellectual Disability: Gene Sequencing and Deletion/Duplication Panel - Removed ABCD1 from gene list

Test Requisitions - Things to Remember

Not completing a test requisition form entirely can sometimes lead to unnecessary delays in testing. Below are the most commonly missed items:

  • ICD9 codes
  • Policy holder name and date of birth
  • If any authorizations are obtained for the patient, please include a copy of the authorizations with the requisition
  • Medicare patients must have a signed Advance Beneficiary Notice of Non-coverage (ABN) included with the requisition, except for following BRCA-related test codes: MM070, MM071, MM072, and MM208. Please note, EGL does not pre-verify benefits for patients with Medicare.
  • Signature in the “Authorization to Assign Benefits” section
  • Front and back copy of the patient’s insurance card
  • Billing pages - regardless of the person or entity to be billed, please complete this information.

Prior Authorization Reminder

When it is determined that a prior authorization is needed for testing, the sample will be placed on a billing hold. EGL will notify the client as to what is required and help with any necessary paperwork.

New and Updated Gene Panels

Industry-leading number of gene panels

EGL Next Generation Sequencing Panels include comprehensive, evidence-based gene lists, improved turnaround times, and reduced pricing.